Lapointe A. Greg's Insider Trades & SAST Disclosures
Lapointe A. Greg's most recent trade in Soligenix Inc was a trade of 8,646 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lapointe A. Greg.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soligenix Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 8,646 | 8,646 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 82.70 per share. | 05 Mar 2024 | 3,000 | 25,487 (0%) | 0% | 82.7 | 248,100 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 7,680 | 30,321 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.04 per share. | 29 Feb 2024 | 1,834 | 28,487 (0%) | 0% | 84.0 | 154,129 | Common Stock |
| SouthState Corporation | Lapointe A. Greg | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 881 | 22,838 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | A. Lapointe Greg | Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.45 per share. | 01 Jan 2024 | 513 | 22,325 (0%) | 0% | 84.5 | 43,323 | Common Stock |
| SouthState Corporation | A. Lapointe Greg | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 461 | 21,537 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Lapointe Greg A. | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 420 | 21,957 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | A. Lapointe Greg | Chief Banking Officer | 31 Dec 2023 | 309 | 22,634 (0%) | 0% | 84.4 | 26,095 | Common Stock | |
| SouthState Corporation | A. Lapointe Greg | Chief Banking Officer | 31 Dec 2023 | 7 | 22,641 (0%) | 0% | 84.4 | 591 | Common Stock | |
| Soligenix Inc | Anthony Lapointe Gregg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 38,136 | 38,136 | - | - | Stock Option (Right to Buy) | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 79.19 per share. | 04 Aug 2023 | 4,000 | 23,676 (0%) | 0% | 79.2 | 316,760 | Common Stock |
| Astria Therapeutics Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 5,213 | 30,067 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.63 per share. | 21 Apr 2023 | 2,391 | 27,676 (0%) | 0% | 68.6 | 164,094 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 80.69 per share. | 22 Feb 2023 | 630 | 24,854 (0%) | 0% | 80.7 | 50,835 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 3,963 | 14,536 | - | - | Performance Share Units | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 2,642 | 9,157 | - | - | Restricted Share Units | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 461 | 25,141 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.36 per share. | 01 Jan 2023 | 451 | 25,110 (0%) | 0% | 76.4 | 34,438 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 420 | 25,561 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | 31 Dec 2022 | 251 | 25,361 (0%) | 0% | 76.4 | 19,166 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | 31 Dec 2022 | 123 | 25,484 (0%) | 0% | 76.4 | 9,392 | Common Stock | |
| Soligenix Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 46,154 | 129,747 | - | - | Stock Option (Right to Buy) | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 82.99 per share. | 01 Aug 2022 | 304 | 24,680 (0%) | 0% | 83.0 | 25,229 | Common Stock |
| Astria Therapeutics Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 13,130 | 31,070 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.21 per share. | 08 Jun 2022 | 6,086 | 24,984 (0%) | 0% | 80.2 | 488,158 | Common Stock |
| Rigel Pharmaceuticals | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 85.60 per share. | 21 Mar 2022 | 300 | 17,940 (0%) | 0% | 85.6 | 25,680 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 82.15 per share. | 08 Mar 2022 | 1,470 | 18,240 (0%) | 0% | 82.2 | 120,761 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Sale of securities on an exchange or to another person at price $ 88.91 per share. | 10 Feb 2022 | 1,454 | 19,710 (0%) | 0% | 88.9 | 129,275 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.49 per share. | 10 Feb 2022 | 1,454 | 21,164 (0%) | 0% | 61.5 | 89,406 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 5,041 | 10,573 | - | - | Performance Share Units | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 1,261 | 20,526 | - | - | Restricted Share Units | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 461 | 19,336 (0%) | 0% | 0 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.11 per share. | 01 Jan 2022 | 239 | 19,097 (0%) | 0% | 80.1 | 19,146 | Common Stock |
| Soligenix Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2021 | 29,126 | 29,126 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 5,532 | 5,532 | - | - | Performance Share Units | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 1,383 | 19,726 | - | - | Restricted Share Units | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | 31 Dec 2020 | 692 | 36,830 (0%) | 0% | 72.3 | 50,032 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | 31 Dec 2020 | 381 | 37,218 (0%) | 0% | 72.3 | 27,546 | Common Stock | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | 31 Dec 2020 | 7 | 36,837 (0%) | 0% | 72.3 | 506 | Common Stock | |
| Soligenix Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 15,228 | 15,228 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| SouthState Corporation | Greg A. Lapointe | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 63.93 per share. | 08 Jun 2020 | 13,130 | 36,138 (0%) | 0% | 63.9 | 839,401 | Common Stock |
| SouthState Corporation | Greg A. Lapointe | President of SSB | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.27 per share. | 07 Jun 2020 | 7,594 | 23,008 (0%) | 0% | 60.3 | 457,690 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges